Quantitative Assessment of Tumor Blood Flow in Mice After Treatment With Different Doses of an Antiangiogenic Agent With Contrast-Enhanced Destruction-Replenishment US

Radiology - United States
doi 10.1148/radiol.10101339
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Radiological Society of North America (RSNA)

Related search

Prostate Cancer Ablation With Transrectal High-Intensity Focused Ultrasound: Assessment of Tissue Destruction With Contrast-Enhanced US

Radiology
Nuclear MedicineRadiologyImaging
2011English

Complete Bubble Destruction Is Essential for Quantitative Assessment From the Replenishment Curve in Real-Time Myocardial Contrast Echocardiography

Journal of Echocardiography
Nuclear MedicineRadiologyImaging
2005English

Correlation of Ultrasound Contrast Agent Derived Blood Flow Parameters With Immunohistochemical Angiogenesis Markers in Murine Xenograft Tumor Models

Ultrasonics
AcousticsUltrasonics
2013English

Contrast-Enhanced Ultrasonography With Quantitative Analysis Allows Differentiation of Renal Tumor Histotypes

Scientific Reports
Multidisciplinary
2016English

Intraoperative Laser Speckle Contrast Imaging With Retrospective Motion Correction for Quantitative Assessment of Cerebral Blood Flow

Neurophotonics
Nuclear MedicineRadiologyUltrasound TechnologyRadiologicalImagingNeuroscience
2014English

Liver Dysplasia: US Molecular Imaging With Targeted Contrast Agent Enables Early Assessment

Radiology
Nuclear MedicineRadiologyImaging
2013English

Tumor Characterization With Dynamic Contrast Enhanced Magnetic Resonance Imaging and Biodegradable Macromolecular Contrast Agents in Mice

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2009English

Deeply Penetrating Photoacoustic Tomography in Biological Tissues Enhanced With an Optical Contrast Agent

Optics Letters
OpticsAtomicMolecular Physics,
2005English

Preclinical Evaluation of Tumor Microvascular Response to a Novel Antiangiogenic/Antitumor Agent RO0281501 by Dynamic Contrast-Enhanced MRI at 1.5 T

Molecular Cancer Therapeutics
Cancer ResearchOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy